Enochian Biosciences Inc. (OTC:ENOB)
Industry: FinancialConglomerates

Enochian Biosciences Inc., a biopharmaceutical company, identifies, develops, manufactures, and commercializes gene therapies for HIV/AIDS and cancer patients. Its lead candidate include ENO-1001 a genetically modified cell therapy for patients with HIV/AIDS. It is also developing ENO-2001, an HIV vaccine; and additional compounds, such as ENO-4001, ENO-4002, ENO-3001, and ENO-5001 that are in discovery stage for prevention of relapse in colon cancer patients. Enochian BioSciences is headquartered in Los Angeles, California.

Current Quote*
Last: $7.475
Change: -0.035
Book: $1.930
Volume: 17,205

As Of: 02/15 13:33 ET
*Quotes delayed by 20min.

Graphs for ENOB

3 Month Graph

6 Month Graph

1 Year Graph